Hypocholesterolaemic effects of lovastatin in familial defective apolipoprotein B-100.

Abstract

Familial defective apolipoprotein B-100 (FDB) is an autosomal dominant disorder associated with hypercholesterolaemia in which an aminoacid substitution in apoprotein B-100 leads to low-density lipoprotein (LDL) particles which have defective binding to the LDL receptor. All known patients are heterozygous, and their plasma contains normal and poorly binding LDL particles. 12 hypercholesterolaemic patients from 10 unrelated families with FDB were treated with lovastatin. In 6 patients treated with 20 mg lovastatin daily, LDL cholesterol decreased by 21.5% from 6.23 to 4.89 mmol/l (95% confidence interval 0.74, 1.96 mmol/l), whereas it fell by 32.1%, from 6.99 to 4.81 mmol/l (95% CI 1.55, 2.70 mmol/l), in 9 patients who received 40 mg daily. These results indicate that the hypercholesterolaemia of FDB may respond to treatment with statins.

Statistics

050100150'94'97'00'03'06'09'12'15
Citations per Year

232 Citations

Semantic Scholar estimates that this publication has 232 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Illingworth1992HypocholesterolaemicEO, title={Hypocholesterolaemic effects of lovastatin in familial defective apolipoprotein B-100.}, author={D. Roger Illingworth and Funda Vakar and Robert W . Mahley and Karl H. Weisgraber}, journal={Lancet}, year={1992}, volume={339 8793}, pages={598-600} }